Dr. Fisch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Unit 462
Houston, TX 77030Phone+1 224-301-7002
Summary
- I am board certified in medical oncology, internal medicine and hospice and palliative medicine. I work full-time as Senior Medical Director of Oncology Programs and Genetics at Carelon Medical Benefits Management, a subsidiary of Elevance Health.
I work part-time as Clinical Professor in the Department of General Oncology at MD Anderson Cancer Center in Houston, Texas. I am also Co-Chair of the Symptom Control and QOL Committee for the SWOG Cancer Research Network.
Education & Training
- Indiana University School of MedicineFellowship, General Oncology, 1995 - 1997
- Indiana UniversityMPH, Health Education, 1997
- Indiana UniversityMPH, Health Education, 1997
- Indiana University School of MedicineFellowship, Hematology and Medical Oncology, 1993 - 1996
- University of Virginia Medical CenterResidency, Internal Medicine, 1990 - 1993
- University of Virginia Medical CenterInternship, Internal Medicine, 1989 - 1990
- University of Virginia School of MedicineClass of 1990
- University of VirginiaBA, Echols Scholar, 1986
- University of VirginiaBA, 1986
Certifications & Licensure
- FL State Medical License 2021 - Present
- VA State Medical License 1997 - 2026
- TX State Medical License 2001 - 2025
- IN State Medical License 1993 - 1997
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hospice and Palliative Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Vicente Valero LBJ Clinician Educator of the Year MD Anderson Cancer Center, 2019
- Fellow of the American Society of Clinical Oncology ASCO, 2016
- Director's Service Award National Cancer Institute, 2014
- Join now to see all
Clinical Trials
- Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy Start of enrollment: 2003 May 20
- Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer
- Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer Start of enrollment: 2006 Mar 14
- Join now to see all
Publications & Presentations
PubMed
- 16 citationsComparison of Acupuncture vs Sham Acupuncture or Waiting List Control in the Treatment of Aromatase Inhibitor-Related Joint Pain: A Randomized Clinical Trial.Dawn L Hershman, Joseph M Unger, Heather Greenlee, Jillian Capodice, Danika L Lew
JAMA Network Open. 2022-11-01 - 6 citationsRandomized phase 2 study of bone‐targeted therapy containing strontium‐89 in advanced castrate‐sensitive prostate cancerMehmet Asim Bilen, Marcella M. Johnson, Paul Mathew, Lance C. Pagliaro, John C. Araujo
Cancer. 2015-01-01 - 34 citationsSymptom burden among young adults with breast or colorectal cancerStacy D. Sanford, Fengmin Zhao, John M. Salsman, Victor T. Chang, Lynne I. Wagner
Cancer. 2014-08-01
Journal Articles
- Effect of Acupuncture vs Sham Acupuncture or Waitlist Control on Joint Pain Related to Aromatase Inhibitors Among Women with Early-Stage Breast CancerA Randomized Clin...Dawn L Hershman, Jillian L Capodice, William H Kreisle, Michael J Fisch, Marianne K Melnik, Alice T Kengla, Carla W Jorgensen, Heather Greenlee, JAMA
- Patient-oncologist alliance as protection against suicidal ideation in young adults with advanced cancerTrevino KM, Abbott CH, Fisch MJ, Friedlander RJ, Duberstein PR, Prigerson HG, Cancer, 5/1/2014
- Determinants of pain severity changes in ambulatory cancer patients: An analysis from ECOG E2Z02Zhao F, Chang VT, Cleeland C, Cleary JF, Mitchell EP, Wagner LI, Fisch MJ, J Clin Oncol, 2/1/2014
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Prediction and early detection of anthracycline-related cardiotoxicity using cardiac biomarkers.Stevens, PL, Lenihan DJ, Ky B, Warneke CL, Johnson MM, Abramson VG, Mayer IA, Adams PT, Campbell MG, Cheema PS, Moore DF, Yeshwant C, Carver JR, BFisch M, J Clin Oncol, 6/1/2014
- Factors asociated with loss of employment among metastatic patients.Tevaarwerk A, Lee JW, Sesto ME, Terhaar A, Smith ML, Cleeland CS, Wagner LI, Fisch M., J Clin Oncol, 5/1/2014
- Clinical risk prediction in anthracycline cardiotoxicity.Ky B, Wameke CL, Lenihan DJ, Cheema PS, Moore DF, Campbell MG, YeshwantC, Adams PT, Krone R, Carver JR, Nasta S, Svoboda J, Schuster SJ, Reddy NM, Patel SM, Rieber AG,..., J Clin Oncol, 5/1/2014
- Join now to see all
Lectures
- The use of optimal evidence-based chemotherapy (chemo) regimens in physician offices versus hospital outpatient facilities.ASCO Annual Meeting 2019 - Chicago, IL - 6/2/2019
- Teaching Critical Thinking and Digital Literacy to Solve Real Problems.Chicago, IL - 11/11/2014
- Pearls From the Lens of an Academic General OncologistMD Anderson Cancer Center, Houston, TX - 7/8/2014
- Join now to see all
Authored Content
- Caring and Learning from Every Patient and Ourselves at ASCOJune 2019
- Caring and Learning from Every Patient and Ourselves at ASCOJune 2019
Press Mentions
- Tumor Is Not the Only Target: Ensuring Equitable Person-Centered Supportive Care in the Era of Precision MedicineJune 1st, 2024
- A First-of-Its-Kind Opportunity to Integrate Training in Medical Oncology, Hematology, and Palliative CareJune 10th, 2022
- 10 Twitter Accounts to Follow for Biotech UpdatesJanuary 29th, 2021
- Join now to see all
Committees
- Member (through 2019), Medicare Evidence Development & Coverage Advisory Committee (MEDCAC) 2016 - 2016
- Member, Ad Hoc Quality Plan Committee 2013 - 2015
- Member, Clinical Faculty Review (Promotion) Committee 2013 - 2015
- Member, Co-Chair (2014), Patient Experience Steering Committee 2012 - 2015
- Member, Physician Relations Faculty Advisory Board 2012 - 2015
- Member (2008-2009, and 2012-2013), Credentialing Committee of the Medical Staff 2012 - 2013
- Member, Executive Billing and Compliance Committee 2008 - 2011
- Chair, Data Safety Monitoring Board, North American Brain Tumor Consortium, Chair, 1/2006−1/2009 2006 - 2009
- Member, Graduate Medical Education Curriculum Committee 2006 - 2008
- Member, MD Anderson Hematology-Oncology Fellowship Steering Committee 2005 - 2015
- Chair, Editorial board, Oncolog: Report to Physicians 2005 - 2015
Professional Memberships
- Fellow
- Fellow
- Member
- Member
External Links
- AIM Websitehttps://aimspecialtyhealth.com/team/michael-j-fisch-md-mph-facp-faahpm-fasco/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: